Merck (MRK) Common Equity (2009 - 2026)
Merck's Common Equity came in at $41.98 billion for Q2 2026, down 14.4% from $49.06 billion a year earlier and down 8.6% from the prior quarter.
Powered by 
Analysis
Merck (MRK) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Merck's Common Equity was $52.66 billion, up 13.6% from FY2024.
- Common Equity carries a five-year compound annual growth rate of 15.7% (FY2020 to FY2025).
- Going back by year, Common Equity was $46.37 billion in FY2024 (+23.2%), $37.64 billion in FY2023 (-18.3%), $46.06 billion in FY2022 (+20.4%) and $38.26 billion in FY2021 (+50.6%).
- The Q2 2026 figure represents the lowest quarterly Common Equity since Q1 2024.
- Year-over-year, Common Equity increased in six of the last eight quarters, with growth averaging 9.2%.
- The fastest year-over-year change in Common Equity over five years came in Q1 2022 (growth of 51.5%), and the weakest in Q4 2023 (a decline of 18.3%).
- Business Quant data shows MRK's Common Equity at $45.93 billion (Q1 2026), $52.66 billion (Q4 2025) and $51.91 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 22.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.98 Bn |
| Mar 31, 2026 | 45.93 Bn |
| Dec 31, 2025 | 52.66 Bn |
| Sep 30, 2025 | 51.91 Bn |
| Jun 30, 2025 | 49.06 Bn |
| Mar 31, 2025 | 48.40 Bn |
| Dec 31, 2024 | 46.37 Bn |
| Sep 30, 2024 | 44.56 Bn |
| Jun 30, 2024 | 43.65 Bn |
| Mar 31, 2024 | 40.42 Bn |
| Dec 31, 2023 | 37.64 Bn |
| Sep 30, 2023 | 41.30 Bn |
| Jun 30, 2023 | 38.74 Bn |
| Mar 31, 2023 | 46.91 Bn |
| Dec 31, 2022 | 46.06 Bn |
| Sep 30, 2022 | 44.52 Bn |
| Jun 30, 2022 | 43.32 Bn |
| Mar 31, 2022 | 40.95 Bn |
| Dec 31, 2021 | 38.26 Bn |
| Sep 30, 2021 | 35.86 Bn |
API Access
Merck Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();